[Application of γ imaging in chromatographic separation and protein molecular site density determination].

Journal: Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi
Published Date:

Abstract

We in this study measured the site density of E-selectin in order to explore the practical pliability using radionuclide labeling method and γ-imaging of single photon emission computer tomography (SPECT). This method required labeling of antibody with I using Indogen method and binding of the labeled antibody to E-selectin. Labeled E-selectin was separated and purified in a Sephadex G25 column. The different fractions of the eluants were imaged, analyzed and quantified with SPECT method. For measuring the saturation curve of E-selectin, 130 μL of E-selectin solution with different concentrations were added in a 48-well plate and incubated overnight at 4℃. After incubation, 130 μL of labeled antibody solution were added and kept incubated for 30 min. The resulted mixture was washed, and the radioactivity in each sample was detected by SPECT. The levels of radioactivity were translated to site densities, and were used to plot a standard curve. The labeled product was quantitatively analyzed with SPECT. The labeling rate of E-selectin was 78%. The saturation curve of different concentration samples showed that when the concentration was in the concentration range of 0-1 mg/mL, the standard curve was =6 045.7 -51.166, =0.997 9. Based on this finding, it could be concluded that γ-imaging is an important tool for analysis of radiolabeled product and determination of site density.

Authors

  • Jinhe Zhang
    Department of Nuclear Medicine, the First Affiliated Hospital, Jinan University, Guangzhou 510632, P.R.China;Department of Nuclear Medicine, General Hospital of Guangzhou Military Command, Guangzhou 510010, P.R.China.
  • Quhuan Li
    School of Bioscience and Bioengineering, South China University of Technology, Guangzhou, China.
  • Yingchen Ling
    School of Bioscience and Bioengineering, South China University of Technology, Guangzhou 510641, P.R.China.
  • Jianqiu Zhong
    Department of Nuclear Medicine, General Hospital of Guangzhou Military Command, Guangzhou 510010, P.R.China.
  • Jilin Yin
    Department of Nuclear Medicine, General Hospital of Guangzhou Military Command, Guangzhou 510010, P.R.China.
  • Hao Xu
    Department of Nuclear Medicine, the First Affiliated Hospital, Jinan University, Guangzhou 510632, P.R.China.gdhyx2012@126.com.

Keywords

No keywords available for this article.